ADVERTISEMENT
Search

 

Press Releases

 

18

May

2022

APhA statement on the recent shooting tragedies

WASHINGTON, DC—The American Pharmacists Association (APhA) is deeply saddened by the horrific mass shootings that occurred over the weekend in Buffalo, NY and Laguna, CA.

Comments (0)
Number of views (1618)
Article rating: No rating

16

May

2022

APhA–APPM, SIGs, and APhA-APRS Announce 2022 Election Results

WASHINGTON, D.C.—The American Pharmacists Association (APhA) announced the results of elections for the Academy of Pharmaceutical Research and Science (APhA–APRS), Academy of Pharmacy Practice and Management (APhA–APPM), and the APhA–APPM Special Interest Groups (SIGs) today.

Comments (0)
Number of views (3452)
Article rating: No rating

5

May

2022

APhA announces results of 2022 Board elections

Author: Renee Kalu

WASHINGTON, D.C.—Today the American Pharmacists Association (APhA) announced the election of Alex C. Varkey, PharmD, MS, FAPhA, of Sugar Land, TX, as 2023–2024 APhA president-elect. Varkey will succeed Valerie Prince, PharmD, FAPhA, BCPS, of Odenville, AL, to the office of APhA president on March 25, 2024, at the conclusion of the 2024 APhA Annual Meeting & Exposition in Orlando, FL.

Comments (0)
Number of views (6420)
Article rating: No rating

4

May

2022

APhA and NASPA release 2021 National State-based Pharmacy Workplace Survey report

WASHINGTON, DC—The American Pharmacists Association (APhA) and the National Alliance of State Pharmacy Associations (NASPA) have released the final report of the 2021 National State-based Pharmacy Workplace Survey.

Comments (0)
Number of views (2584)
Article rating: No rating

2

May

2022

APhA appreciates CMS’ elimination of retroactive DIR fees

Though more actions are needed to address PBMs’ harmful business practices

Author: Renee Kalu

WASHINGTON, D.C.—CMS has issued a final rule eliminating Part D plans’ and PBMs’ use of retroactive direct and indirect remuneration (DIR) fees beginning on January 1, 2024 (contract year 2024). The American Pharmacists Association (APhA) and many of its members submitted comments to CMS on the proposal. APhA appreciates CMS’ efforts to end the uncertainty and lack of drug cost transparency at the pharmacy caused by retroactive DIR fees.

Comments (0)
Number of views (4393)
Article rating: No rating
RSS
123468910Last